Noncontraceptive estrogen use and cardiovascular disease

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Lipidology

Background:

• Estrogens exert significant influence on biological parameters impacting cardiovascular disease (CVD) risk.
• Key effects include modulation of lipid and lipoprotein levels, with potential implications for atherosclerosis and myocardial infarction.
• The role of estrogens in glucose metabolism and coagulation requires further elucidation regarding CVD risk.

Purpose of the Study:

• To summarize the multifaceted effects of estrogens on biological parameters relevant to cardiovascular disease risk.
• To analyze the conflicting evidence regarding estrogen's influence on thromboembolic events versus atherogenic processes.
• To explore potential differences in estrogen's cardiovascular effects between men and women.

Main Methods:

• Review and synthesis of existing scientific literature on estrogen's biological effects.
• Analysis of studies examining estrogen's impact on lipid profiles (LDL, HDL), glucose metabolism, coagulation, and blood pressure.
• Comparison of findings across different populations (men vs. women) and dosages.

Main Results:

• Estrogens consistently decrease low-density lipoprotein (LDL) and increase high-density lipoprotein (HDL), suggesting a favorable impact on CVD risk.
• Estrogens can temporarily alter glucose tolerance, with unclear clinical significance for CVD risk.
• Evidence regarding adverse effects on coagulation and blood pressure is inconsistent, though potential risks exist in specific individuals.
• Conflicting results in men (increased thromboembolism, decreased atherosclerosis) may relate to higher estrogen doses and pre-existing atherosclerotic burden.

Conclusions:

• Estrogenic effects on lipid/lipoprotein levels are the most consistent and potent, likely offering protection against cardiovascular disease.
• A dual action of estrogens, potentially increasing thromboembolic risk while decreasing atherogenic risk, may explain varied clinical outcomes.
• Endogenous estrogen levels appear most consistently protective against cardiovascular disease in women.